Directory
>
Michael Pine
Michael Pine
Chief Business Officer | EyePoint Pharmaceuticals
United States
Michael Pine
Summary
Michael Pine is a seasoned executive with over 20 years of experience in the pharmaceutical industry, currently serving as the Chief Business Officer at EyePoint Pharmaceuticals. He holds a B.S. from Cornell University and an MBA from Columbia Business School, which have equipped him with a robust foundation in economics, strategy, and management. Michael has played a pivotal role in shaping corporate strategies and executing high-stakes mergers and acquisitions across various reputable firms, including Pfizer and Novartis. His expertise spans business development, market access, and strategic partnerships, making him a valuable asset in navigating the complexities of the biopharmaceutical landscape. Michael is not only adept at leading cross-functional teams but also at fostering strong professional networks that enhance collaborative efforts. His commitment to tackling industry challenges and his innovative approach to problem-solving have consistently driven significant value for the organizations he has worked with. He is also passionate about mentoring others and sharing insights gained throughout his career.
Michael Pine
Work Experience
Chief Business Officer at
EyePoint Pharmaceuticals
January 2022 - Present
Chief Corporate Development & Strategy Officer at
EyePoint Pharmaceuticals
January 2022 - October 2023
Senior Vice President Business Development & Strategy at
Medexus Pharmaceuticals
September 2020 - January 2022
Independent BD Consultant at
Independent Consultant
June 2020 - August 2020
Senior Vice President Business Development - Global Specialty (Branded) Products at
Lupin
February 2019 - May 2020
Vice President, Corporate Development & Licensing at
Aralez Pharmaceuticals Canada Inc.
August 2015 - January 2019
Director, Head of Operations & Analytics, US Managed Markets at
Novartis
December 2013 - July 2015
Director, Market Access Strategies, US Managed Markets at
Novartis
August 2011 - December 2013
Marketing & Alliance Management at
Novartis
February 2010 - August 2011
Director, US Business Development & Licensing at
Novartis
April 2007 - July 2011
Director, Business Development & Licensing at
Kos Pharmaceuticals
January 2006 - March 2007
Director of Business Development at
Organon Pharmaceuticals
August 2004 - January 2006
Senior Manager - New Product Development Licensing & Acquisitions at
Pfizer, Inc.
November 2001 - August 2004
Assistant Brand Manager at
WYETH
May 2000 - August 2000
Sr. Financial Analyst at
JPMorganChase
July 1997 - August 1999
Michael Pine
Education
Columbia Business School, Mba
January 1999 - January 2001
January 1994 - January 1997
Frequently Asked Questions about Michael Pine
What is Michael Pine email address?
Michael Pine's primary email address is *****@eyepointpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Pine work for?
Michael Pine is a Chief Business Officer at EyePoint Pharmaceuticals, a company specializing in Commercial physical research.
Where Michael Pine graduated from?
Michael Pine holds a degree in Strategy, Marketing, Management, Finance from Columbia Business School.
How can I directly contact Michael Pine?
To contact Michael Pine directly, you can use the email address *****@eyepointpharma.com. Complete contact information is available upon registration with Muraena.
Who is Michael Pine?
Michael Pine is a seasoned executive with over 20 years of experience in the pharmaceutical industry, currently serving as the Chief Business Officer at EyePoint Pharmaceuticals. He holds a B.S. from Cornell University and an MBA from Columbia Business School, which have equipped him with a robust foundation in economics, strategy, and management. Michael has played a pivotal role in shaping corporate strategies and executing high-stakes mergers and acquisitions across various reputable firms, including Pfizer and Novartis. His expertise spans business development, market access, and strategic partnerships, making him a valuable asset in navigating the complexities of the biopharmaceutical landscape. Michael is not only adept at leading cross-functional teams but also at fostering strong professional networks that enhance collaborative efforts. His commitment to tackling industry challenges and his innovative approach to problem-solving have consistently driven significant value for the organizations he has worked with. He is also passionate about mentoring others and sharing insights gained throughout his career.
Michael`s contact details
*****@eyepointpharma.com
Colleagues
President and CEO
Senior Vice President and Chief Technology Officer
Chief Legal Officer & Company Secretary
VP, Chief of Staff
Vice President, Clinical Development -Ophthalmology
Vice President, Clinical Operations
Vice President Of Quality
VP, Market Access Strategy, Reimbursement and Government Affairs
Vice President, Intellectual Property
Member